Revolution Medicines, Inc. Accrued Royalties increased by 4.5% to $280.64M in Q1 2026 compared to the prior quarter.
other_accrued_royalties_current_and_noncurrent| Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $0.00 | $245.08M | $256.51M | $268.45M | $280.64M |
| QoQ Change | — | — | +4.7% | +4.7% | +4.5% |